Utilizing an NTG rat migraine model, the CB1-selective antagonist rimonabant completely restored hyperalgesia under conditions where AEA concentrations were raised either by inhibition of the degradation enzyme FAAH or in FAAH knockout rats, indicating that CB1 alone is responsible for the analgesic effect of AEA [69]. Here, FAAH is linked to migraine disorder.